$138 Million is the total value of Copernicus Capital Management, LLC's 19 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 55.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SYK | Buy | STRYKER CORP | $11,855,000 | +41.7% | 70,209 | +35.0% | 8.60% | +29.0% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $11,526,000 | +26.9% | 55,645 | +26.5% | 8.37% | +15.6% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $11,518,000 | +18.3% | 24,073 | +2.1% | 8.36% | +7.7% |
| ILMN | Buy | ILLUMINA INC | $11,486,000 | +23.1% | 41,124 | +4.2% | 8.34% | +12.1% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $11,292,000 | +32.6% | 66,440 | +27.2% | 8.20% | +20.8% |
| DVA | Buy | DAVITA INC | $9,548,000 | +53.8% | 137,496 | +46.1% | 6.93% | +40.1% |
| CVS | New | CVS HEALTH CORP | $8,726,000 | – | 135,595 | +100.0% | 6.33% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $8,443,000 | +100.6% | 58,000 | +92.3% | 6.13% | +82.8% |
| HOLX | New | HOLOGIC INC | $6,738,000 | – | 169,511 | +100.0% | 4.89% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $6,427,000 | +71.2% | 141,345 | +98.8% | 4.66% | +56.0% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $5,823,000 | +3.1% | 372,798 | -0.7% | 4.23% | -6.1% |
| HRTX | Buy | HERON THERAPEUTICS INC | $5,609,000 | +88.2% | 144,382 | +33.7% | 4.07% | +71.4% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $4,812,000 | +124.3% | 286,797 | +118.2% | 3.49% | +104.4% |
| ZTS | Buy | ZOETIS INCcl a | $4,763,000 | +2.4% | 55,905 | +0.4% | 3.46% | -6.7% |
| NUVA | Buy | NUVASIVE INC | $4,582,000 | +0.2% | 87,906 | +0.4% | 3.33% | -8.7% |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $4,058,000 | – | 63,000 | +100.0% | 2.94% | – |
| HSIC | New | SCHEIN HENRY INC | $3,995,000 | – | 55,000 | +100.0% | 2.90% | – |
| MOH | Sell | MOLINA HEALTHCARE INC | $3,598,000 | -52.5% | 36,737 | -60.7% | 2.61% | -56.8% |
| HUM | New | HUMANA INC | $2,976,000 | – | 10,000 | +100.0% | 2.16% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -28,100 | -100.0% | -2.00% | – |
| SCI | Exit | SERVICE CORP INTL | $0 | – | -92,796 | -100.0% | -2.79% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -4.44% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -116,506 | -100.0% | -7.00% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -33,296 | -100.0% | -7.26% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -55,000 | -100.0% | -7.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 15 | Q2 2021 | 28.6% |
| THERMO FISHER SCIENTIFIC INC | 10 | Q3 2021 | 13.8% |
| ZOETIS INC | 10 | Q1 2020 | 13.0% |
| FATE THERAPEUTICS INC | 9 | Q3 2021 | 13.7% |
| ILLUMINA INC | 9 | Q4 2019 | 11.8% |
| BIOMARIN PHARMACEUTICAL INC | 8 | Q3 2021 | 14.7% |
| BRISTOL-MYERS SQUIBB CO | 8 | Q4 2020 | 12.2% |
| INTUITIVE SURGICAL INC | 7 | Q2 2019 | 11.8% |
| STRYKER CORP | 7 | Q2 2019 | 11.6% |
| IQVIA HLDGS INC | 7 | Q4 2020 | 8.2% |
View Copernicus Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
View Copernicus Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.